Soria F, Shariat SF, Lerner SP, et al. Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC). World J Urol. 2017;35:379–87.

Article  PubMed  Google Scholar 

Petros FG. Epidemiology, clinical presentation, and evaluation of upper-tract urothelial carcinoma. Transl Androl Urol. 2020;9:1794–8.

Article  PubMed  PubMed Central  Google Scholar 

Sfakianos JP, Gul Z, Shariat SF, Matin SF, Daneshmand S, Plimack E, Lerner S, Roupret M, Pal S. Genetic differences between bladder and upper urinary tract carcinoma: implications for therapy. Eur Urol Oncol. 2021;4:170–9.

Article  PubMed  Google Scholar 

Fujii Y, Sato Y, Suzuki H, et al. Molecular classification and diagnostics of upper urinary tract urothelial carcinoma. Cancer Cell. 2021;39:793-809.e8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Necchi A, Madison R, Pal SK, et al. Comprehensive genomic profiling of upper-tract and bladder urothelial carcinoma. Eur Urol Focus. 2021;7:1339–46.

Article  PubMed  Google Scholar 

CollàRuvolo C, Wenzel M, Nocera L, et al. The effect of race on stage at presentation and survival in upper tract urothelial carcinoma. Urol Oncol: Semin Orig Investig. 2021;39:788.e7-788.e13.

Article  Google Scholar 

Lonati C, Moschini M, Simeone C, Spiess PE, Necchi A. Lynch syndrome in urological practice: diagnosis, therapeutic strategies, and screening for upper tract urothelial carcinoma. Curr Opin Urol. 2022;32:40–7.

Article  PubMed  Google Scholar 

Roberts JL, Ghali F, Aganovic L, Bechis S, Healy K, Rivera-Sanfeliz G, Autorino R, Derweesh I. Diagnosis, management, and follow-up of upper tract urothelial carcinoma: an interdisciplinary collaboration between urology and radiology. Abdom Radiol. 2019;44:3893–905.

Article  Google Scholar 

Schuettfort VM, Pradere B, Quhal F, et al. Diagnostic challenges and treatment strategies in the management of upper-tract urothelial carcinoma. Türk Üroloji Dergisi/Turk J Urol. 2021;47:S33–44.

Article  Google Scholar 

Petros FG, Qiao W, Singla N, Clinton TN, Robyak H, Raman JD, Margulis V, Matin SF. Preoperative multiplex nomogram for prediction of high-risk nonorgan-confined upper-tract urothelial carcinoma. Urol Oncol: Semin Orig Investig. 2019;37:292.e1-292.e9.

Article  Google Scholar 

Yates DR, Hupertan V, Colin P, et al. Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram. Br J Cancer. 2012;106:1083–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ku JH, Moon KC, Jung JH, Jeong SH, Kwak C, Kim HH. External validation of an online nomogram in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma. Br J Cancer. 2013;109:1130–6.

Article  CAS  PubMed  Google Scholar 

Katims AB, Gaffney C, Firouzi S, et al. Feasibility and tissue concordance of genomic sequencing of urinary cytology in upper tract urothelial carcinoma. Urol Oncol: Semin Orig Investig. 2023;41:433.e19-433.e24.

Article  CAS  Google Scholar 

Evmorfopoulos K, Mitrakas L, Karathanasis A, Zachos I, Tzortzis V, Vlachostergios PJ. Upper tract urothelial carcinoma: a rare malignancy with distinct immuno-genomic features in the era of precision-based therapies. Biomedicines. 2023;11:1775.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grahn A, Coleman JA, Eriksson Y, et al. Consultation on UTUC II Stockholm 2022: diagnostic and prognostic methods—what’s around the corner? World J Urol. 2023;41:3405–11.

Article  PubMed  PubMed Central  Google Scholar 

Grahn A, Eisfeldt J, Malm C, ForoughiAsl H, Jaremko G, Tham E, Brehmer M. Genomic profile – a possible diagnostic and prognostic marker in upper tract urothelial carcinoma. BJU Int. 2022;130:92–101.

Article  CAS  PubMed  Google Scholar 

Yip W, Kim K, Kuo F, et al. Upper tract urothelial carcinoma transcriptome profiling and immune microenvironment characterization. J Clin Oncol. 2022;40:564–564.

Article  Google Scholar 

Van Allen EM, Mouw KW, Kim P, et al. Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma. Cancer Discov. 2014;4:1140–53.

Article  PubMed  PubMed Central  Google Scholar 

Hirotsu Y, Yokoyama H, Amemiya K, Hagimoto T, Hosaka K, Oyama T, Mochizuki H, Omata M. Genomic profiling identified ERCC2 E606Q mutation in helicase domain respond to platinum-based neoadjuvant therapy in urothelial bladder cancer. Front Oncol. 2020. https://doi.org/10.3389/fonc.2020.01643.

Article  PubMed  PubMed Central  Google Scholar 

Tang Q, Zuo W, Wan C, Xiong S, Xu C, Yuan C, Sun Q, Zhou L, Li X. Comprehensive genomic profiling of upper tract urothelial carcinoma and urothelial carcinoma of the bladder identifies distinct molecular characterizations with potential implications for targeted therapy & immunotherapy. Front Immunol. 2023. https://doi.org/10.3389/fimmu.2022.1097730.

Article  PubMed  PubMed Central  Google Scholar 

Chalfin HJ, Glavaris SA, Gorin MA, et al. Circulating tumor cell and circulating tumor DNA assays reveal complementary information for patients with metastatic urothelial cancer. Eur Urol Oncol. 2021;4:310–4.

Article  PubMed  Google Scholar 

Green EA, Li R, Albiges L, Choueiri TK, Freedman M, Pal S, Dyrskjøt L, Kamat AM. Clinical utility of cell-free and circulating tumor DNA in kidney and bladder cancer: a critical review of current literature. Eur Urol Oncol. 2021;4:893–903.

Article  PubMed  Google Scholar 

Vandekerkhove G, Lavoie J-M, Annala M, et al. Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer. Nat Commun. 2021;12:184.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huelster HL, Gould B, Schiftan EA, et al. Novel use of circulating tumor DNA to identify muscle-invasive and non–organ-confined upper tract urothelial carcinoma. Eur Urol. 2024;85:283–92.

Article  CAS  PubMed  Google Scholar 

Mu N, Jylhä C, Axelsson T, Sydén F, Brehmer M, Tham E. Patient-specific targeted analysis of circulating tumour DNA in plasma is feasible and may be a potential biomarker in UTUC. World J Urol. 2023;41:3421–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tamura D, Abe M, Hiraki H, et al. Postoperative recurrence detection using individualized circulating tumor DNA in upper tract urothelial carcinoma. Cancer Sci. 2024;115:529–39.

Article  CAS  PubMed  Google Scholar 

Subiela JD, Territo A, Mercadé A, et al. Diagnostic accuracy of ureteroscopic biopsy in predicting stage and grade at final pathology in upper tract urothelial carcinoma: systematic review and meta-analysis. Eur J Surg Oncol. 2020;46:1989–97.

Article  PubMed  Google Scholar 

Uhlén M, Karlsson MJ, Hober A, et al. The human secretome. Sci Signal. 2019. https://doi.org/10.1126/scisignal.aaz0274.

Article  PubMed  Google Scholar 

Giudice G, Petsalaki E. Proteomics and phosphoproteomics in precision medicine: applications and challenges. Brief Bioinform. 2019;20:767–77.

Article  CAS  PubMed  Google Scholar 

Qu Y, Yao Z, Xu N, et al. Plasma proteomic profiling discovers molecular features associated with upper tract urothelial carcinoma. Cell Rep Med. 2023;4:101166.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu C-M, Lin J-J, Huang H-H, Ko Y-C, Hsu J-L, Chen J-C, Din Z-H, Wu Y-J. A panel of tumor markers, calreticulin, annexin A2, and annexin A3 in upper tract urothelial carcinoma identified by proteomic and immunological analysis. BMC Cancer. 2014;14:363.

Article  PubMed  PubMed Central  Google Scholar 

Li P, Tao J, Wei D, et al. Serum metabolomic analysis of human upper urinary tract urothelial carcinoma. Tumor Biology. 2015;36:7531–7.

Article